Bill

Bill > HB1772


NH HB1772

NH HB1772
Relative to prescribing ibogaine for investigational use only and adopting the physician associate licensure compact.


summary

Introduced
12/17/2025
In Committee
05/07/2026
Crossed Over
03/17/2026
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

This bill: I. Permits licensed health care providers to administer ibogaine under the framework of an FDA-approved research protocol. II. Adopts the PA licensure compact.

AI Summary

This bill allows licensed healthcare providers to administer ibogaine, a substance being researched for its potential therapeutic uses, but only within the strict guidelines of a research protocol approved by the U.S. Food and Drug Administration (FDA), ensuring it's used for investigational purposes and under federal oversight. Additionally, the bill adopts the Physician Associate Licensure Compact, which is an agreement between states to allow physician associates (PAs), also known as physician assistants, to practice in multiple participating states more easily. This compact aims to improve access to healthcare services by creating a streamlined process for PA licensure portability while maintaining patient safety standards and facilitating the practice of PAs, particularly benefiting military families by easing licensure for active-duty personnel and their spouses.

Committee Categories

Health and Social Services

Sponsors (8)

Last Action

Conference Committee Meeting: 05/27/2026 01:45 pm GP 231 (on 05/27/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...